The CHOPAN registry aims to collect real-time data on pregnant women who are infected with the coronavirus that causes COVID-19 (SARS-CoV2) to improve our understanding of its impact on pregnancy outcomes. This registry will provide regular feedback to clinicians and public health officials to allow evidence-based management of women and their babies with coronavirus infection.
This registry was developed by Australian clinicians in collaboration with international colleagues in order to maximise its value to the global community.
The aims of the registry are to:
1. Describe the presentation and clinical course of coronavirus infection in pregnant women
2. Assess obstetric, perinatal and neonatal outcomes after coronavirus infection
3. Describe modes of transmission, including any cases of mother-to-child transmission
4. Identify any factors that influence disease outcome for mother and baby including: timing and mode of delivery, breastfeeding, rooming-in/separation, the use of anti-viral treatments and supportive therapies
5. Facilitate international collaborative efforts to improve care of women exposed to novel and emergent pathogens.
The aim of the NCOS project is to investigate the population health impacts of COVID -19 in mothers and their newborn infants cared for in tertiary and non-tertiary neonatal facilities. The research questions/hypothesis this study seeks to address include:
1. Incidence of COVID-19 in pregnant women and their newborn infants
2. Describe the outcomes for mothers and their newborn infants with COVID-19
3. Identify incidence of SARS-CoV-2 infection in the neonatal period and describe clinical course and outcomes for newborn infants with COVID-19
4. Collaborate with international COVID-19 registries to inform global variations and outcomes in care of newborn infants